Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial.

Creamer, Andrew W; Barratt, Shaney L.

Afiliação

Creamer AW; Respiratory Medicine, North Bristol NHS Trust, Westbury on Trym, UK.
Barratt SL; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Westbury on Trym, UK.

Breathe (Sheff) ; 15(2): 140-143, 2019 Jun.

Article em En | MEDLINE | ID: mdl-31191728

ABSTRACT

The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http//ow.ly/uHC030nEzsz.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article